Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Placebo comparator

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    1,804 result(s) found for: Placebo comparator. Displaying page 12 of 91.
    «« First « Previous 8  9  10  11  12  13  14  15  16  Next» Last»»
    EudraCT Number: 2020-003131-16 Sponsor Protocol Number: 20584 Start Date*: 2021-01-25
    Sponsor Name:Bayer AG
    Full Title: A randomized, double-blind, open for active comparator, parallel-group, multicenter Phase 2b study to assess the efficacy and safety of three different doses of P2X3 antagonist (BAY 1817080) versus...
    Medical condition: Treatment of pain related to endometriosis
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004872 10014788 Endometriosis related pain LLT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) CZ (Completed) SK (Completed) FI (Completed) NO (Completed) AT (Completed) LT (Completed) PL (Completed) BE (Completed) BG (Prematurely Ended) HU (Completed) GR (Completed) EE (Completed) LV (Completed) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-000006-23 Sponsor Protocol Number: CV181039 Start Date*: 2007-02-12
    Sponsor Name:Bristol-Myers Squibb International Corporation
    Full Title: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin in Combination with Metformin IR as Initial Therapy Compared to Saxaglip...
    Medical condition: Type 2 Diabetes Mellitus
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) DE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2015-003622-13 Sponsor Protocol Number: 1311.28 Start Date*: 2016-03-07
    Sponsor Name:SCS Boehringer Ingelheim Comm.V
    Full Title: BI 655066 versus Ustekinumab and placebo comparators in a randomized double blind trIal for Maintenance use in Moderate to severe plaque type psoriasis-2 (UltIMMa-2)
    Medical condition: Psoriasis
    Disease: Version SOC Term Classification Code Term Level
    18.1 10040785 - Skin and subcutaneous tissue disorders 10037153 Psoriasis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) DE (Completed) AT (Completed) PT (Completed) ES (Completed) PL (Completed) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-003891-20 Sponsor Protocol Number: NL17389.091.07 Start Date*: 2007-11-27
    Sponsor Name:GGZ Nijmegen
    Full Title: Een gerandomiseerde placebo gecontroleerde studie naar de toegevoegde waarde van D-cycloserine aan exposure therapie bij patiënten met een poststraumatische stress stoornis
    Medical condition: Posttraumatic stress disorder
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036876 Prolonged posttraumatic stress disorder LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-000847-28 Sponsor Protocol Number: 39916 Start Date*: 2012-11-19
    Sponsor Name:Isala Klinieken Zwolle
    Full Title: Efficacy of Arnica D1 ointment after upper blepharoplasty: a randomized, double-blind placebo-controlled study
    Medical condition: Blepharoplasty of upper eyelid
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-004297-40 Sponsor Protocol Number: Version 3 February 2010 Start Date*: 2008-04-25
    Sponsor Name:University Hospitals of Leicester NHS Trust
    Full Title: Pharmacological treatment of nystagmus: A randomised double masked placebo controlled crossover study using gabapentin and memantine.
    Medical condition: Nystagmus
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2017-001848-35 Sponsor Protocol Number: APB-MET-2017-01 Start Date*: 2017-12-14
    Sponsor Name:Juan Blanco Carrion
    Full Title: METRONIDAZOLE AS AN ADJUNCT OF NON-SURGICAL TREATMENT OF PERI-IMPLANTITIS: A 6-MONTHS PLACEBO-CONTROLLED CLINICAL TRIAL IN HUMANS.
    Medical condition: Peri-implantitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-006846-24 Sponsor Protocol Number: HTA074801 Start Date*: 2009-02-27
    Sponsor Name:North West London Hospitals NHS Trust
    Full Title: An Evaluation of the Effectiveness of Ibuprofen and Morphine for Acute Pain in Sickle Cell Disease
    Medical condition: Sickle Cell Disease
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-005953-31 Sponsor Protocol Number: STAB 1 Start Date*: 2007-05-03
    Sponsor Name:GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
    Full Title: Inhibition of Dental Plaque Regrowth by an Ethanol-Free 0,2% Chlorhexidine Mouth Rinsing Solution
    Medical condition: The purpose of this study is to examine the inhibitory effect of an ethanol-free 0,2% chlorhexidine digluconate (CHX) mouthrinse on the bacterial plaque growth after professional tooth cleaning in ...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-000954-22 Sponsor Protocol Number: CI-1008-100 Start Date*: 2004-09-23
    Sponsor Name:Pfizer Global Research & Development
    Full Title: A 1-Year Open-Label Safety Extension Study of Pregabalin (CI-1008) in Patients With Anxiety Disorders
    Medical condition: Generalized Anxiety Disorder
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2016-003131-38 Sponsor Protocol Number: DOPA2016 Start Date*: 2017-06-23
    Sponsor Name:TARGID, KU Leuven
    Full Title: The effect of chlorpromazine (Largactil), a dopamine type 2-(D2-) receptor antagonist, on esophageal sensitivity in healthy volunteers: a randomized, double-blind, placebo-controlled study
    Medical condition: Increased esophageal sensitivity in refractory gastro-esophageal reflux disease
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2013-004332-29 Sponsor Protocol Number: food_intake Start Date*: 2013-12-18
    Sponsor Name:UZLeuven
    Full Title: The influence of erythromycin and bitter administration on ad libitum food intake in healthy volunteers and patients
    Medical condition: The effect of erythromycin administration on voluntary food intake will be tested in healthy volunteers, obese patients and patients with unexplained weight loss
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2015-001946-26 Sponsor Protocol Number: AMITNED Start Date*: 2016-01-19
    Sponsor Name:Aarhus University Hospital
    Full Title: Amilorid treatment of nephrotic edema
    Medical condition: Childhood idiopathic nephrotic syndrome (NS)
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-002449-12 Sponsor Protocol Number: 2013-002449-12 Start Date*: 2013-11-19
    Sponsor Name:Westfriesgasthuis
    Full Title: Does buprenorphine (Temgesic) 0,3 mg prolongs the analgesic effect of a blockade of the femoral nerve with 20 ml ropivacaïne HCL Fresenius Kabi 0,2% for patiënts with a total knee replacement. A pr...
    Medical condition: -
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-001953-24 Sponsor Protocol Number: WON001 Start Date*: 2007-07-21
    Sponsor Name:University of Dundee
    Full Title: ''Metformin in Insulin Resistant LV Dysfunction, a double-blind, placebo-controlled trial''
    Medical condition: Patients who has heart failure and found to be insulin resistant (pre-diabetic state). Insulin resistance can be identified using a blood test.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-004689-42 Sponsor Protocol Number: RGHT000298 Start Date*: 2008-07-29
    Sponsor Name:Belfast Health and Social Care Trust
    Full Title: Insulin action and hypertension: effects of hyperaldosteronism and its treatment.
    Medical condition: The effect of eplerenone on insulin action is being studied in patients with mild essential hypertension.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-000493-23 Sponsor Protocol Number: A2260335 Start Date*: 2007-04-05
    Sponsor Name:GlaxoSmithKline Consumer Healthcare
    Full Title: A Comparison of Two Analgesic Products for the Treatment of Headache
    Medical condition: Treatment of tension headache
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-002557-68 Sponsor Protocol Number: CDJN608 FI01 Start Date*: 2006-11-06
    Sponsor Name:Hospital District of Southwest Finland
    Full Title: A randomized, double-blind, placebo-controlled study to evaluate the efficacy of zoledronic acid in enhancement of early stability of cementless primary hip prosthesis
    Medical condition: Bone loss occurring around cementless hip prosthesis in postmenopausal women treated for primary hip osteoarthritis
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-004862-89 Sponsor Protocol Number: mirtazapine1 Start Date*: 2015-02-16
    Sponsor Name:KULeuven
    Full Title: The effect of mirtazapine (REMERGON®) on gastric motility and satiation in healthy subjects
    Medical condition: Functional Dyspepsia
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2015-003637-96 Sponsor Protocol Number: NL54748.078.15 Start Date*: 2016-03-31
    Sponsor Name:
    Full Title: DD-study: diet or diuretics for salt-sensitivity in chronic kidney disease
    Medical condition: Hypertension in chronic kidney disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 8  9  10  11  12  13  14  15  16  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 14 09:53:09 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA